Boğaziçi CT3 - Social Media

Social Media

Son Paylaşımlar

05.10.2026

We are growing our team at Boğaziçi CT³

Boğaziçi CT³ is growing its team and looking for new colleagues across research, technology transfer, scientific projects, medical device development, imaging, and science communication.

04.10.2026

We’re wrapping up TEKNOFEST 2026 with an award!

At ISIF’26, Boğaziçi CT³ showcased six registered inventions and received a Bronze Medal for its “ImmuneFixed Tumor-Cell Preparation System.”

04.10.2026

Boğaziçi CT³ is at TASSA 2026!

At TASSA 2026, Boğaziçi CT³ showcased its research infrastructure and opportunities for collaboration, research, and careers in health technologies to the international scientific community.

29.09.2026

Boğaziçi CT³ and Boğaziçi TTO are at TEKNOFEST!

At ISIF’26 as part of TEKNOFEST, Boğaziçi CT³ and Boğaziçi TTO showcased innovative technologies and patented inventions, highlighting the journey from research to commercialization.

25.09.2026

Bilim Herkes İçin, Herkes Bilim İçin!

As part of SCIENCE4ALL, Boğaziçi CT³ joined the European Researchers’ Night Science Festival, bringing scientific discovery closer to young audiences.

13.09.2026

Boğaziçi CT Joint Event #9

About the talk: "Nanoparticle-biomolecule interactions: The next horizon for antibiotics"

02.09.2026

A New Collaboration in the MedTech & BioTech Ecosystem

We have signed a new collaboration to support the transformation of innovative ideas in healthcare technologies into products and sustainable ventures.

28.08.2026

SCIENCE4ALL

It is a national science festival and a European Researchers’ Night event aimed at bringing science closer to society.

15.08.2026

Cell and Protein Technologies Platform

We look forward to welcoming you to this inspiring session at the intersection of computational medicine, drug discovery, and next-generation therapeutics.

07.08.2026

SCIENCE4ALL KICK-OFF

We held the Kick-Off meeting for our SCIENCE4ALL project at Istinye University on Wednesday, August 5, 2026.

03.08.2026

How Reliable Are Your Osmium Results?

We continue to provide reliable and traceable analytical solutions in accordance with OECD GLP standards throughout research and drug development processes.

28.07.2026

The Horizon Europe WIDERA Twinning 2026 Programme

Through international collaboration, researcher exchanges, training programmes, and cutting-edge AI research, ENLIGHT-AI will strengthen scientific excellence and contribute to the future of digital health.

23.06.2026

San Diego for BIO International Convention 2026

Meet Bogazici CT³ at BIO 2026 and let’s connect to build impactful biotech and medtech partnerships!

23.06.2026

“From Molecule to Medicine” Research Summer School

Organized by Boğaziçi CT³, the “From Molecule to Medicine” Research Summer School is a five-day intensive science program specially designed for high school students interested in natural sciences and research.

19.06.2026

Boğaziçi CT³ & LifeSci Laboratory Animal Use Certificate Training Program

As part of the program, participants received theoretical and practical training on ethical principles, national and international regulations, various methods, and experimental models used in research involving laboratory animals.

15.06.2026

TÜSEB 2026 Group B R&D Project Call

As Boğaziçi University Center for Targeted Therapy Technologies (CT³), we are proud that three of our healthcare technology projects have been selected for support under TÜSEB’s Group B R&D Project Call.

12.06.2026

Boğaziçi CT³ Open Event #7

At our event, “Beyond Medicine: A Transcontinental Entrepreneur’s Journey in Personalized Drug Development,” we explored the transformation of scientific research into innovative therapies, the dynamics of biotechnology entrepreneurship, and recent developments in personalized medicine.

11.06.2026

Boğaziçi CT³ Open Event #6

At our event, “Beyond Targeted Therapies: A Translational Biotechnology Perspective on Diagnostics, Engineering, and Entrepreneurship,” we were delighted to welcome our esteemed professor, Prof. Dr. Özge Can.

04.06.2026

TÜSEB Delegation’s Visit to the HTTM Center

As Boğaziçi University Center for Targeted Therapy Technologies (Boğaziçi HTTM / @bogazicict3), we were pleased to welcome a delegation from the Turkish Health Institutes Presidency (TÜSEB) to our center.

03.06.2026

Boğaziçi CT³ Open Event #7

As Boğaziçi University Center for Targeted Therapy Technologies (HTTM / CT³), we are pleased to welcome a distinguished physician, scientist, and biotechnology entrepreneur to the 7th edition of our Open Events Series.

02.06.2026

Boğaziçi CT³ Open Event #6

As Boğaziçi University Center for Targeted Therapy Technologies (HTTM / CT³), we are delighted to welcome a distinguished academic and researcher to the 6th edition of our Open Events Series.

24.05.2026

OECD Good Laboratory Practice (GLP) Compliance Statement

With our GLP- and GCP-compliant infrastructure and advanced analytical capabilities, we provide reliable, traceable, and high-quality services in accordance with rigorous quality standards.

02.05.2026

Laboratory Animal Use Certificate Training Program

This training program covers ethical principles, the 3Rs approach, experimental design, and practical laboratory techniques, and is designed for researchers, students, and professionals working with laboratory animals.

28.04.2026

Boğaziçi CT³ Joint Event #8

We look forward to welcoming you to this informative session at the intersection of biomaterials, engineering design, and technology-driven biomedical innovation.

28.04.2026

Boğaziçi HTTM Was at Expomed Eurasia 2026!

At Expomed Eurasia 2026, one of the meeting points for innovation in healthcare technologies, we represented Boğaziçi University Center for Targeted Therapy Technologies at the Innovation Area.

16.04.2026

Expomed Eurasia 2026 | İnovasyon Alanı Etkinlikleri #2

At the “Entrepreneurship in Healthcare from the Perspective of Young Professionals” panel, opportunities, challenges, and critical decision-making moments in the healthcare entrepreneurship journey were discussed.

15.04.2026

Expomed Eurasia 2026 | İnovasyon Alanı Etkinlikleri #1

As part of Expomed Eurasia, our project was presented on April 16, 2026, during the Innovation Area Events organized in collaboration with İSEK and TÜSEB.

14.04.2026

Boğaziçi CT³ Joint Event #7

In the seventh joint seminar organized with the Boğaziçi University Biomedical Engineering Institute (BME), we will explore how medicine-particularly mental health-is evolving at the intersection of human experience, social context, and technological systems.

14.04.2026

A Historic Milestone for Türkiye’s Drug Development Ecosystem

The successful completion of RS-0139’s Phase 1 clinical trial marks a major milestone in Türkiye’s drug development journey. This achievement highlights Boğaziçi CT³’s translational R&D strength, spanning from basic science to clinical applications.

09.04.2026

The Phase 1 Clinical Trial of Our Cancer Drug Has Been Completed!

The Phase 1 clinical trial of the drug developed by Prof. Dr. Rana Sanyal, a faculty member at Boğaziçi University’s Department of Chemistry, for cancer treatment has been completed.

08.04.2026

The DIGI4AGE EDIH Project

We believe that such engagements play a critical role in fostering meaningful connections and translating innovation into real-world impact. Looking forward to future collaboration opportunities.

07.04.2026

Boğaziçi CT³ Joint Event #6

We believe that such engagements play a critical role in fostering meaningful connections and translating innovation into real-world impact. Looking forward to future collaboration opportunities.

24.03.2026

Boğaziçi CT³ Joint Event #5

We look forward to welcoming you to this informative session at the intersection of engineering tools, biomedical research, and technology-driven innovation.

12.03.2026

Boğaziçi CT³ Joint Event #4

We look forward to welcoming you to this inspiring session at the intersection of digital health, entrepreneurship, and globally scalable health technology innovation.

06.03.2026

Boğaziçi CT³ Joint Event #3

We look forward to welcoming you to this inspiring session at the intersection of nanomedicine, photonic technologies, and next-generation cancer therapeutics.

26.02.2026

Boğaziçi CT³ Joint Event #2

We look forward to welcoming you to this inspiring session at the intersection of biotechnology, ethical innovation, and sustainable industrial transformation.

12.02.2026

Boğaziçi CT³ Open Event #5

As part of our Strategic Partnerships and Business Development Seminars, this time we are set to explore a real deep-tech entrepreneurship journey spanning the path from the laboratory to AI models.

11.02.2026

Boğaziçi CT³ Joint Event #1

About the talk: "Targeting the Immune System With Extracellular Vesicles"

06.02.2026

“From Molecule to Medicine” Research Winter School

Boğaziçi University Center for Targeted Therapy Technologies (Boğaziçi CT³) completed the “From Molecule to Medicine” Research Winter School on January 30, 2026.

21.01.2026

DIGI4AGE Project and the Digital Europe Programme (DEP)

With this development, Boğaziçi University has assumed the coordination and leadership of a digital health and artificial intelligence-focused center within the ADİM ecosystem, contributing to Türkiye’s digital transformation.

15.01.2026

Boğaziçi CT³ Open Event #4

At this event, bringing together perspectives from academia, entrepreneurship, technology, and the wider ecosystem, more open, connected, and impactful models of innovation spanning local to global contexts were explored.

16.12.2025

Our OECD Good Laboratory Practice (GLP) Compliance Statement

With our OECD Good Laboratory Practice (GLP) Compliance Statement, we became part of a strong laboratory ecosystem built on shared quality standards.

16.10.2025

Boğaziçi CT³ - IBG Panel

The panel “Personalized Medicine and Targeted Therapy Technologies in Rare Diseases and Cancer: Sharing Experiences, A Shared Vision for the Future” was held on October 17, 2025, at the Aspendos Hall.

03.10.2025

Boğaziçi CT³ at Bioexpo 2025!

We welcomed visitors to accelerate their journey from the laboratory to the market and foster new collaborations.

29.09.2025

Boğaziçi CT³ at the IPA Health and Food Workshop!

Boğaziçi CT³ participated in the IPA Health and Food Workshop organized by the Ministry of Industry and Technology, sharing its journey from LifeSci to the present, the impact of its IPA-supported infrastructure on the healthcare technology ecosystem, and roadmaps for future collaborations.

23.09.2025

Boğaziçi CT³ Open Event #2

At the second event of the Boğaziçi CT³ Open Events Series, we explored “Commercializing Innovation in Life Sciences: Creating Impact through Patent Strategies.”

15.09.2025

Boğaziçi CT³ 2TECH Meeting #14

About the talk: "3D Bioprinting & Tissue Engineering"

25.07.2025

“From Molecule to Medicine” Research Summer School

11.06.2025

Science and Innovation Converged at the 3ʳᵈ Targeted Therapy Technologies Symposium

The 3ʳᵈ Targeted Therapy Technologies Symposium, at Boğaziçi University’s Kandilli Campus, brought together more than 25 scientists, clinicians, and health technology experts to explore advances in nanomedicine, tissue engineering, medical devices, diagnostics, and translational medicine.

11.06.2025

3ʳᵈ Targeted Therapy Technologies Symposium Session #6

At Session 6 of the 3ʳᵈ Targeted Therapy Technologies Symposium, translational research and academia–industry collaborations in biomedical engineering, diagnostics, implants, and therapeutic nanotechnologies were explored.

11.06.2025

3ʳᵈ Targeted Therapy Technologies Symposium Session #5

At Session 5 of the 3ʳᵈ Targeted Therapy Technologies Symposium, innovative research in nanomedicine focusing on nanoparticle-mediated drug delivery, gene targeting, tumor microenvironments, and photothermal agents was explored.

11.06.2025

3ʳᵈ Targeted Therapy Technologies Symposium Session #4

At Session 4 of the 3ʳᵈ Targeted Therapy Technologies Symposium, innovative research in biomaterials, 3D/4D printing, and tissue models for translational therapies was explored.

10.06.2025

3ʳᵈ Targeted Therapy Technologies Symposium Session #3

At Session 3 of the 3ʳᵈ Targeted Therapy Technologies Symposium, the translation of discoveries in microbiome science, pathology, immunotherapy, and pharmacology into clinical practice and the future of translational medicine were explored.

05.06.2025

3ʳᵈ Targeted Therapy Technologies Symposium Session #2

At Session 2 of the 3ʳᵈ Targeted Therapy Technologies Symposium, innovations in digital health, precision oncology, cardiovascular digital twins, and biomarker-driven cancer management were explored.

04.06.2025

3ʳᵈ Targeted Therapy Technologies Symposium Session #1

At Session 1 of the 3ʳᵈ Targeted Therapy Technologies Symposium, innovations in imaging, theranostics, and smart peptide technologies, along with emerging approaches shaping the future of diagnostics, were explored.

26.05.2025

3ʳᵈ Targeted Therapy Technologies Symposium

Latest developments in translational research, spanning nanomedicine- and cell-based therapies, tissue engineering, advanced medical devices, and diagnostics, were explored.

Mavi: Aktif post • Gri: Post yok